RecoverLINK Technology Pilot for HF Patients
Pilot to Assess Feasibility of Using RecoverLINK Technology to Supplement Outpatient Care for Heart Failure Patients
1 other identifier
interventional
46
1 country
1
Brief Summary
The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Feb 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 22, 2016
CompletedFirst Posted
Study publicly available on registry
June 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedAugust 31, 2018
August 1, 2018
2.2 years
June 22, 2016
August 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
User engagement: # symptom surveys completed/30 days
30 days
User satisfaction: Percent patients report "satisfied" via post-program survey
30 days
Workflow efficiency: mean/median time to resolution of patient alerts
30 days
Secondary Outcomes (2)
Mean difference in pre/post SCHIFI score
30 days
Hospital admission
30, 60, 90 days
Study Arms (1)
RecoverLINK technology
EXPERIMENTALRecoverLINK is a two-part mHealth technology designed to supplement traditional care transitional programs for heart failure (HF) patients.
Interventions
HF patients will receive the RecoverLINK app upon study enrollment for 30-days. The Mount Sinai HF care team will interact with patients via the RecoverLINK cloud-based system during this period
Eligibility Criteria
You may qualify if:
- Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount Sinai HF clinic
- English-speaking
- With either access to (i) an iOS smart device or (ii) wifi at-home
You may not qualify if:
- Patients meeting any of the following criteria:
- A heart transplant
- A mechanical circulatory support (MCS) device
- An altered mental status
- Serious co-morbidities (as identified by Mount Sinai team)
- Cognitive impairments (as identified by Mount Sinai team)
- Inability to use technology (as identified by Mount Sinai team)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RecoverLINKlead
- Mount Sinai Hospital, New Yorkcollaborator
- Digital Health Marketplace (previously Pilot Health Tech NYC)collaborator
Study Sites (1)
The Mount Sinai Hospital
New York, New York, 10029, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sean Pinney, MD
The Mount Sinai Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2016
First Posted
June 28, 2016
Study Start
February 1, 2016
Primary Completion
April 1, 2018
Study Completion
June 1, 2018
Last Updated
August 31, 2018
Record last verified: 2018-08